Problem statement: Answer the multiple-choice question.
Question: What is the human ether-à-go-go related gene (hERG) inhibition at 10uM of a compound with the SMILES CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)Nc4ccc(O)c(C(=O)O)c4)ccc3OCC)nc12?
Constraint: You must return none, one or more options from a, b, c, or d without using any other words.
Options:
a) -18.390
b) -3.425
c) -15.210
d) -45.194
Answer: b. -3.425%.
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: What is the {herg_central_at_10uM__names__noun} of a {#compound|drug!} with the {SMILES__description} {SMILES#}?
Constraint: You must return none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{herg_central_at_10uM%SMILES%}
Answer: {%multiple_choice_result}. {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)Nc4ccc(O)c(C(=O)O)c4)ccc3OCC)nc12
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)Nc4ccc(O)c(C(=O)O)c4)ccc3OCC)nc12
5-[[4-ethoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)phenyl]sulfonylamino]-2-hydroxybenzoic acid